Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pre-Exposure Prophylaxis Market Growth 2021-2026

  • LP 4667989
  • 89 Pages
  • November 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
According to this latest study, the 2021 growth of Pre-Exposure Prophylaxis will have significant change from previous year. By the most conservative estimates of global Pre-Exposure Prophylaxis market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Pre-Exposure Prophylaxis market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Exposure Prophylaxis market by product type, application, key manufacturers and key regions and countries.

Segmentation by brand: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Truvada

Discovy

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Adult

Adolescent

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Gilead Sciences

Teva Pharmaceuticals

Strides Pharma Science

Lupin

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pre-Exposure Prophylaxis Consumption 2016-2026

2.1.2 Pre-Exposure Prophylaxis Consumption CAGR by Region

2.2 Pre-Exposure Prophylaxis Segment by Brand

2.2.1 Truvada

2.2.2 Discovy

2.3 Pre-Exposure Prophylaxis Sales by Brand

2.3.1 Global Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

2.3.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Brand (2016-2021)

2.3.3 Global Pre-Exposure Prophylaxis Sale Price by Brand (2016-2021)

2.4 Pre-Exposure Prophylaxis Segment by Application

2.4.1 Adult

2.4.2 Adolescent

2.5 Pre-Exposure Prophylaxis Sales by Application

2.5.1 Global Pre-Exposure Prophylaxis Sale Market Share by Application (2016-2021)

2.5.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Application (2016-2021)

2.5.3 Global Pre-Exposure Prophylaxis Sale Price by Application (2016-2021)

3 Global Pre-Exposure Prophylaxis by Company

3.1 Global Pre-Exposure Prophylaxis Sales Market Share by Company

3.1.1 Global Pre-Exposure Prophylaxis Sales by Company (2019-2021)

3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Company (2019-2021)

3.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Company

3.2.1 Global Pre-Exposure Prophylaxis Revenue by Company (2019-2021)

3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2019-2021)

3.3 Global Pre-Exposure Prophylaxis Sale Price by Company

3.4 Global Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pre-Exposure Prophylaxis Product Location Distribution

3.4.2 Players Pre-Exposure Prophylaxis Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Pre-Exposure Prophylaxis by Region

4.1 Global Pre-Exposure Prophylaxis by Region

4.1.1 Global Pre-Exposure Prophylaxis Sales by Region

4.1.2 Global Pre-Exposure Prophylaxis Revenue by Region

4.2 Americas Pre-Exposure Prophylaxis Sales Growth

4.3 APAC Pre-Exposure Prophylaxis Sales Growth

4.4 Europe Pre-Exposure Prophylaxis Sales Growth

4.5 Middle East & Africa Pre-Exposure Prophylaxis Sales Growth

5 Americas

5.1 Americas Pre-Exposure Prophylaxis Sales by Country

5.1.1 Americas Pre-Exposure Prophylaxis Sales by Country (2016-2021)

5.1.2 Americas Pre-Exposure Prophylaxis Revenue by Country (2016-2021)

5.2 Americas Pre-Exposure Prophylaxis Sales by Brand

5.3 Americas Pre-Exposure Prophylaxis Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pre-Exposure Prophylaxis Sales by Region

6.1.1 APAC Pre-Exposure Prophylaxis Sales by Region (2016-2021)

6.1.2 APAC Pre-Exposure Prophylaxis Revenue by Region (2016-2021)

6.2 APAC Pre-Exposure Prophylaxis Sales by Brand

6.3 APAC Pre-Exposure Prophylaxis Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pre-Exposure Prophylaxis by Country

7.1.1 Europe Pre-Exposure Prophylaxis Sales by Country (2016-2021)

7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Country (2016-2021)

7.2 Europe Pre-Exposure Prophylaxis Sales by Brand

7.3 Europe Pre-Exposure Prophylaxis Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pre-Exposure Prophylaxis by Country

8.1.1 Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2016-2021)

8.1.2 Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2016-2021)

8.2 Middle East & Africa Pre-Exposure Prophylaxis Sales by Brand

8.3 Middle East & Africa Pre-Exposure Prophylaxis Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Pre-Exposure Prophylaxis Distributors

10.3 Pre-Exposure Prophylaxis Customer

11 Global Pre-Exposure Prophylaxis Market Forecast

11.1 Global Pre-Exposure Prophylaxis Forecast by Region

11.1.1 Global Pre-Exposure Prophylaxis Forecast by Regions (2021-2026)

11.2.2 Global Pre-Exposure Prophylaxis Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Pre-Exposure Prophylaxis Forecast by Brand

11.7 Global Pre-Exposure Prophylaxis Forecast by Application

12 Key Players Analysis

12.1 Gilead Sciences

12.1.1 Gilead Sciences Company Information

12.1.2 Gilead Sciences Pre-Exposure Prophylaxis Product Offered

12.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Gilead Sciences Main Business Overview

12.1.5 Gilead Sciences Latest Developments

12.2 Teva Pharmaceuticals

12.2.1 Teva Pharmaceuticals Company Information

12.2.2 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Offered

12.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Teva Pharmaceuticals Main Business Overview

12.2.5 Teva Pharmaceuticals Latest Developments

12.3 Strides Pharma Science

12.3.1 Strides Pharma Science Company Information

12.3.2 Strides Pharma Science Pre-Exposure Prophylaxis Product Offered

12.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Strides Pharma Science Main Business Overview

12.3.5 Strides Pharma Science Latest Developments

12.4 Lupin

12.4.1 Lupin Company Information

12.4.2 Lupin Pre-Exposure Prophylaxis Product Offered

12.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Lupin Main Business Overview

12.4.5 Lupin Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Pre-Exposure Prophylaxis Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Truvada

Table 3. Major Players of Discovy

Table 4. Global Pre-Exposure Prophylaxis Sales by Brand (2016-2021) & (K Units)

Table 5. Global Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

Table 6. Global Pre-Exposure Prophylaxis Revenue by Brand (2016-2021) & ($ million)

Table 7. Global Pre-Exposure Prophylaxis Revenue Market Share by Brand (2016-2021)

Table 8. Global Pre-Exposure Prophylaxis Sale Price by Brand (2016-2021)

Table 9. Global Pre-Exposure Prophylaxis Sales by Application (2016-2021) & (K Units)

Table 10. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Table 11. Global Pre-Exposure Prophylaxis Value by Application (2016-2021)

Table 12. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2016-2021)

Table 13. Global Pre-Exposure Prophylaxis Sale Price by Application (2016-2021)

Table 14. Global Pre-Exposure Prophylaxis Sales by Company (2019-2021) & (K Units)

Table 15. Global Pre-Exposure Prophylaxis Sales Market Share by Company (2019-2021)

Table 16. Global Pre-Exposure Prophylaxis Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2019-2021)

Table 18. Global Pre-Exposure Prophylaxis Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution and Sales Area

Table 20. Players Pre-Exposure Prophylaxis Products Offered

Table 21. Pre-Exposure Prophylaxis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Pre-Exposure Prophylaxis Sales by Region (2016-2021) (K Units)

Table 25. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2016-2021)

Table 26. Global Pre-Exposure Prophylaxis Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2016-2021)

Table 28. Americas Pre-Exposure Prophylaxis Sales by Country (2016-2021) & (K Units)

Table 29. Americas Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2021)

Table 30. Americas Pre-Exposure Prophylaxis Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2021)

Table 32. Americas Pre-Exposure Prophylaxis Sales by Type (2016-2021) & (K Units)

Table 33. Americas Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

Table 34. Americas Pre-Exposure Prophylaxis Sales by Application (2016-2021) & (K Units)

Table 35. Americas Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Table 36. APAC Pre-Exposure Prophylaxis Sales by Region (2016-2021) & (K Units)

Table 37. APAC Pre-Exposure Prophylaxis Sales Market Share by Region (2016-2021)

Table 38. APAC Pre-Exposure Prophylaxis Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Pre-Exposure Prophylaxis Revenue Market Share by Region (2016-2021)

Table 40. APAC Pre-Exposure Prophylaxis Sales by Brand (2016-2021) & (K Units)

Table 41. APAC Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

Table 42. APAC Pre-Exposure Prophylaxis Sales by Application (2016-2021) & (K Units)

Table 43. APAC Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Table 44. Europe Pre-Exposure Prophylaxis Sales by Country (2016-2021) & (K Units)

Table 45. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2021)

Table 46. Europe Pre-Exposure Prophylaxis Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2021)

Table 48. Europe Pre-Exposure Prophylaxis Sales by Type (2016-2021) & (K Units)

Table 49. Europe Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

Table 50. Europe Pre-Exposure Prophylaxis Sales by Application (2016-2021) & (K Units)

Table 51. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Pre-Exposure Prophylaxis Sales by Brand (2016-2021) & (K Units)

Table 57. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Brand (2016-2021)

Table 58. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Pre-Exposure Prophylaxis

Table 61. Key Application and Potential Industries of Pre-Exposure Prophylaxis

Table 62. Key Challenges of Pre-Exposure Prophylaxis

Table 63. Key Trends of Pre-Exposure Prophylaxis

Table 64. Pre-Exposure Prophylaxis Distributors List

Table 65. Pre-Exposure Prophylaxis Customer List

Table 66. Global Pre-Exposure Prophylaxis Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Pre-Exposure Prophylaxis Consumption Market Forecast by Region

Table 68. Global Pre-Exposure Prophylaxis Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Pre-Exposure Prophylaxis Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Pre-Exposure Prophylaxis Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Pre-Exposure Prophylaxis Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Pre-Exposure Prophylaxis Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Pre-Exposure Prophylaxis Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Pre-Exposure Prophylaxis Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Pre-Exposure Prophylaxis Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Pre-Exposure Prophylaxis Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Pre-Exposure Prophylaxis Sales Forecast by Brand (2021-2026) & (K Units)

Table 79. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Brand (2021-2026)

Table 80. Global Pre-Exposure Prophylaxis Revenue Forecast by Brand (2021-2026) & ($ Millions)

Table 81. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Brand (2021-2026)

Table 82. Global Pre-Exposure Prophylaxis Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Pre-Exposure Prophylaxis Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Application (2021-2026)

Table 86. Gilead Sciences Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors

Table 87. Gilead Sciences Pre-Exposure Prophylaxis Product Offered

Table 88. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Gilead Sciences Main Business

Table 90. Gilead Sciences Latest Developments

Table 91. Teva Pharmaceuticals Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors

Table 92. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Offered

Table 93. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Teva Pharmaceuticals Main Business

Table 95. Teva Pharmaceuticals Latest Developments

Table 96. Strides Pharma Science Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors

Table 97. Strides Pharma Science Pre-Exposure Prophylaxis Product Offered

Table 98. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Strides Pharma Science Main Business

Table 100. Strides Pharma Science Latest Developments

Table 101. Lupin Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors

Table 102. Lupin Pre-Exposure Prophylaxis Product Offered

Table 103. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Lupin Main Business

Table 105. Lupin Latest Developments

List of Figures

Figure 1. Picture of Pre-Exposure Prophylaxis

Figure 2. Pre-Exposure Prophylaxis Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pre-Exposure Prophylaxis Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Pre-Exposure Prophylaxis Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Pre-Exposure Prophylaxis Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Truvada

Figure 10. Product Picture of Discovy

Figure 11. Global Pre-Exposure Prophylaxis Sales Market Share by Brand in 2020

Figure 12. Global Pre-Exposure Prophylaxis Revenue Market Share by Brand (2016-2021)

Figure 13. Pre-Exposure Prophylaxis Consumed in Adult

Figure 14. Global Pre-Exposure Prophylaxis Market: Adult (2016-2021) & (K Units)

Figure 15. Pre-Exposure Prophylaxis Consumed in Adolescent

Figure 16. Global Pre-Exposure Prophylaxis Market: Adolescent (2016-2021) & (K Units)

Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2021)

Figure 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Application in 2020

Figure 19. Pre-Exposure Prophylaxis Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Pre-Exposure Prophylaxis Revenue Market Share by Company in 2020

Figure 21. Global Pre-Exposure Prophylaxis Sales Market Share by Regions (2016-2021)

Figure 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Region in 2020

Figure 23. Americas Pre-Exposure Prophylaxis Sales 2016-2021 (K Units)

Figure 24. Americas Pre-Exposure Prophylaxis Revenue 2016-2021 ($ Millions)

Figure 25. APAC Pre-Exposure Prophylaxis Sales 2016-2021 (K Units)

Figure 26. APAC Pre-Exposure Prophylaxis Revenue 2016-2021 ($ Millions)

Figure 27. Europe Pre-Exposure Prophylaxis Sales 2016-2021 (K Units)

Figure 28. Europe Pre-Exposure Prophylaxis Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Pre-Exposure Prophylaxis Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa Pre-Exposure Prophylaxis Revenue 2016-2021 ($ Millions)

Figure 31. Americas Pre-Exposure Prophylaxis Sales Market Share by Country in 2020

Figure 32. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country in 2020

Figure 33. Americas Pre-Exposure Prophylaxis Sales Market Share by Brand in 2020

Figure 34. Americas Pre-Exposure Prophylaxis Sales Market Share by Application in 2020

Figure 35. United States Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Pre-Exposure Prophylaxis Sales Market Share by Region in 2020

Figure 40. APAC Pre-Exposure Prophylaxis Revenue Market Share by Regions in 2020

Figure 41. APAC Pre-Exposure Prophylaxis Sales Market Share by Brand in 2020

Figure 42. APAC Pre-Exposure Prophylaxis Sales Market Share by Application in 2020

Figure 43. China Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Pre-Exposure Prophylaxis Sales Market Share by Country in 2020

Figure 50. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country in 2020

Figure 51. Europe Pre-Exposure Prophylaxis Sales Market Share by Brand in 2020

Figure 52. Europe Pre-Exposure Prophylaxis Sales Market Share by Application in 2020

Figure 53. Germany Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Brand in 2020

Figure 61. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application in 2020

Figure 62. Egypt Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Pre-Exposure Prophylaxis Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390